In summary, we demonstrated that ANXA5 suppresses COX-2 expression via inhibition of NF-κB p65 phosphorylation, which is regulated by alteration of PKC-ζ protein levels in prostate cancer cells. The gene discussed is NFKB1; the disease is Familial prostate cancer.